Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes.

Pettigrew KA, McKnight AJ, Martin RJ, Patterson CC, Kilner J, Sadlier D, Maxwell AP, Savage DA; Warren 3/UK GoKinD Study Group.

Diabet Med. 2008 Sep;25(9):1127-9. doi: 10.1111/j.1464-5491.2008.02540.x. No abstract available.

PMID:
18937679
2.

Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2003 Aug;14(8):2015-24.

3.

Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.

Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D.

Diabetes Care. 2006 Apr;29(4):864-8.

PMID:
16567829
4.

Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort.

Uthra S, Raman R, Mukesh BN, Rajkumar SA, Kumari PR, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G.

Ophthalmic Genet. 2010 Mar;31(1):18-23. doi: 10.3109/13816810903426231.

PMID:
20141354
5.

Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes.

Currie D, Maxwell AP, Sadlier D, McKnight AJ; Warren 3/UK GoKinD Study Group.

Diabet Med. 2008 Aug;25(8):1001-5. doi: 10.1111/j.1464-5491.2008.02511.x.

PMID:
18959617
6.

[Polymorphism of the angiotensinogen gene and genetic predisposition to diabetic nephropathy in type I diabetes mellitus].

Chistiakov DA, Turakulov RI, Kondrat'ev IaIu, Shestakova MV, Nosikov VV, Dedov II, Debabov VG.

Mol Biol (Mosk). 1999 Mar-Apr;33(2):211-3. Russian. No abstract available.

PMID:
10377565
7.

Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.

Martin RJ, Savage DA, Patterson CC, Brady HR, Maxwell AP.

Diabet Med. 2007 Mar;24(3):259-65.

PMID:
17263760
8.

Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.

Araki S, Makita Y, Canani L, Ng D, Warram JH, Krolewski AS.

Diabetologia. 2000 Dec;43(12):1540-3.

PMID:
11151764
9.

The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.

Schön S, Prante C, Bahr C, Tarnow L, Kuhn J, Kleesiek K, Götting C.

Diabetes Care. 2006 Oct;29(10):2295-9.

PMID:
17003309
10.

Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus.

McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP; Warren 3/UK GoKinD Study Group.

Diabetologia. 2009 May;52(5):844-9. doi: 10.1007/s00125-009-1281-3. Epub 2009 Feb 27.

PMID:
19247629
11.

The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patients.

Dyer PH, Chowdhury TA, Dronsfield MJ, Dunger D, Barnett AH, Bain SC.

Diabetologia. 1999 Aug;42(8):1030-1. No abstract available.

PMID:
10491768
12.

A pilot study on genetic variation in purine-rich elements in the nephrin gene promoter in type 2 diabetic patients.

González R, Tirado A, Balanda M, Alvo M, Barquín I, Durruty P, Lobos S, Seelenfreund D.

Biol Res. 2007;40(3):357-64. doi: /S0716-97602007000400010. Epub 2008 Apr 17.

13.

[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow].

Spitsina EV, Iakunina NIu, Chudakova DA, Nikitin AG, Svetlova GN, Soluianova TN, Strokov IA, Nosikov VV.

Mol Biol (Mosk). 2007 Nov-Dec;41(6):989-93. Russian.

PMID:
18318116
14.

Association between (AC)n dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene and diabetic nephropathy: a meta-analysis.

Xu M, Chen X, Yan L, Cheng H, Chen W.

J Mol Endocrinol. 2008 May;40(5):243-51. doi: 10.1677/JME-07-0152.

15.

Gene discovery in diabetic nephropathy.

Savage DA, Bain SC, McKnight AJ, Maxwell AP.

Curr Diab Rep. 2007 Apr;7(2):139-45. Review.

PMID:
17425918
16.

Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.

Savage DA, Patterson CC, Deloukas P, Whittaker P, McKnight AJ, Morrison J, Boulton AJ, Demaine AG, Marshall SM, Millward BA, Thomas SM, Viberti GC, Walker JD, Sadlier D, Maxwell AP, Bain SC.

Diabetologia. 2008 Nov;51(11):1998-2002. doi: 10.1007/s00125-008-1142-5. Epub 2008 Sep 5.

17.

Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.

Hendig D, Tarnow L, Kuhn J, Kleesiek K, Götting C.

Clin Chim Acta. 2008 Dec;398(1-2):90-4. doi: 10.1016/j.cca.2008.08.019. Epub 2008 Aug 28.

PMID:
18789912
18.

Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy.

McKnight AJ, Maxwell AP, Fogarty DG, Sadlier D, Savage DA; Warren 3/UK GoKinD Study Group.

Nephrol Dial Transplant. 2009 Aug;24(8):2473-6. doi: 10.1093/ndt/gfp015. Epub 2009 Mar 31.

19.

CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients.

Johannesen J, Tarnow L, Parving HH, Nerup J, Pociot F.

Diabetes Care. 2000 Apr;23(4):560-2. No abstract available.

20.

Genetics of diabetes and its complications.

Rich SS.

J Am Soc Nephrol. 2006 Feb;17(2):353-60. Epub 2006 Jan 4. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk